Food produces a typical pattern QTcF shortening which is predictable, reproducible and can be demonstrated even in small populations of around 10 volunteers.Further to our publication �Shortening of the QT Interval After Food Can Be Used to Demonstrate Assay Sensitivity in Thorough QT Studies� published October 2012 in the Journal of Clinical Pharmacology, it is proposed that food effects on ECG demonstrated in SAD and MAD studies can be used to show assay sensitivity thereby enhancing the value of the ECG assessment in these studies significantly.Richmond Pharmacology will present on this topic at the 33rd Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics, taking place this year in Okinawa from 29 Nov to 1 Dec. The presentation will be held on Day 2, from 14h30-15h50 (Room 4 - Conference Hall B3+4).View programContact us to arrange a face-to-face meeting

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event